Aug 2026
Integrated in silico and in vivo approaches reveal naltrexone as a synergistic modulator of TLR4 and μ-opioid receptors restoring redox homeostasis via Nrf2/Keap-1/HO-1 and HIF-1α/VEGF pathways in COPD
Soni, A. Srivastava, Pratikkumar Gaglani et al.
· Molecular and Cellular Bioch... · 0 citations